← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 1993Last known activity
Oct 31, 2024
Timeline
1920s
- Jan 1, 1923
Institut Bergonié— Founded
Drugs by trial phase (76 distinct, 60 trials)
Phase 3 (34 own, 0 via acquisition)
Phase 2 (40 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma of Lung
- Biliary Tract Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Ovarian Epithelial
- Chondrosarcoma
- Chondrosarcoma, Clear Cell
- Chondrosarcoma, Mesenchymal
- Colonic Neoplasms
- Colorectal Neoplasms
- Desmoid Tumors
- Gastrointestinal Stromal Tumors
- Hodgkin Disease
- Inflammatory Breast Neoplasms
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Chronic-Phase
- Liposarcoma
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Meningeal Carcinomatosis
- Meningitis
- Neoplasm Metastasis
- Neoplasms
- Neoplastic Cells, Circulating
- Neuroendocrine Tumors
- Osteosarcoma
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Peritoneal Neoplasms
- Postoperative Pain
- Prostatic Neoplasms
- Recurrence
- Sarcoma
- Sarcoma, Ewing
- Stomach Neoplasms
- Thyroid Neoplasms
- Triple Negative Breast Neoplasms
- Urinary Bladder Neoplasms
Recent trials (50)
- NCT06524583CollaboratorPhase 2Oct 31, 2024
- NCT06084689Lead sponsorPhase 2Jan 1, 2024
- NCT06084689Overall official - principal investigatorPhase 2Jan 1, 2024
- NCT05888857Lead sponsorPhase 2Sep 30, 2023
- NCT05572476Lead sponsorPhase 2Apr 30, 2023
- NCT05346848Lead sponsorPhase 2Nov 30, 2022
- NCT05182164Lead sponsorPhase 2Apr 25, 2022
- NCT04968106Lead sponsorPhase 2Nov 1, 2021
- NCT04874311Lead sponsorPhase 2Nov 1, 2021
- NCT04807816Lead sponsorPhase 2Oct 31, 2021
- NCT04705818Lead sponsorPhase 2Jul 7, 2021
- NCT04339218Overall official - principal investigatorPhase 3Jun 30, 2020
- NCT04339218Lead sponsorPhase 3Jun 30, 2020
- NCT04095208Lead sponsorPhase 2Nov 30, 2019
- NCT04113226Overall official - principal investigatorPhase 2Oct 31, 2019
Details
- Founded
- Bordeaux, FR Jan 1, 1923
- Last known activity
- Oct 31, 2024